COX2 rs689465: Understanding Your Genetic Variant
The rs689465 variant is a specific change located within the PTGS2 gene, which encodes the cyclooxygenase-2 (COX-2) enzyme. Researchers study this variant to understand if it influences individual susceptibility to inflammatory conditions and how the body responds to certain environmental or dietary factors.
What each genotype means
Potential inflammatory susceptibility
This genotype is sometimes referred to in literature as the -1290A variant. Research has explored its potential association with susceptibility to certain inflammatory conditions and cancers, though findings are inconsistent across different populations and studies. If you are concerned about inflammatory health or medication response, please discuss your health history with your clinician.
Frequency varies significantly by ancestry, with the A allele observed at moderate levels in many global populations.
Common genetic variant
This heterozygous genotype contains both the A and G alleles of the rs689465 variant. Studies investigating this site in the COX-2 gene have produced mixed results regarding its influence on disease risk, and it is often studied alongside other linked variants in the same gene. There is no consensus on a specific clinical impact for this genotype, so please consult a healthcare provider for personalized medical advice.
This is a common genotype found in many populations worldwide.
Baseline genetic profile
This genotype represents the G allele at the rs689465 position, which is often considered the reference or major allele in many studies. While some research suggests that variations in the COX-2 gene may influence inflammatory responses, this specific genotype is generally not associated with a distinct clinical phenotype. Please discuss any concerns regarding inflammatory conditions or medication efficacy with your doctor.
This is the most frequently observed genotype in many global populations.
What is the rs689465 Variant?
The rs689465 variant is a single nucleotide polymorphism (SNP) found in the promoter region of the PTGS2 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. Because this variant is located in the promoter region—a segment of DNA that acts as an 'on-off' switch for gene expression—scientists hypothesize that it may affect how much COX-2 protein a cell produces. By altering the efficiency of this switch, the variant could theoretically change the baseline levels of inflammation-related enzymes in the body. It is frequently studied alongside other nearby variants in the same gene, as these markers often exist in linkage disequilibrium, meaning they are inherited together more often than would be expected by chance.
The Role of the COX-2 Gene
The PTGS2 gene provides instructions for making the cyclooxygenase-2 (COX-2) enzyme. This enzyme plays a critical role in the production of prostaglandins, which are lipid compounds that act as signaling molecules in the body. Prostaglandins are essential for various physiological processes, including the regulation of inflammation, pain perception, and the protection of the stomach lining. Under normal conditions, COX-2 expression is tightly regulated and often low, but it is rapidly induced in response to stress, injury, or inflammatory stimuli. Because of its central role in the inflammatory pathway, the COX-2 enzyme is a primary target for nonsteroidal anti-inflammatory drugs (NSAIDs), which work by inhibiting the enzyme's activity to reduce pain and swelling.
Research and Associations
Scientific research into rs689465 has yielded mixed results, reflecting the complexity of genetic associations. Some studies have investigated its potential link to cancer susceptibility, such as prostate cancer, with one study in a Japanese population suggesting an increased risk associated with the AA genotype. However, other studies examining different conditions, such as breast cancer or irritable bowel syndrome, have found no significant association. Because inflammation is a multifactorial process influenced by diet, lifestyle, and thousands of other genetic variants, the impact of a single SNP like rs689465 is often subtle and difficult to isolate. The evidence strength for this variant remains moderate, and findings are often specific to certain populations or disease models, meaning they cannot be broadly generalized to all individuals.
Interpreting Your Genetic Information
It is important to understand that having a particular genotype for rs689465 does not determine your health outcomes. Genetic variants are only one piece of a much larger puzzle that includes your environment, diet, and overall medical history. If you have received information about this variant from a direct-to-consumer test, it is best viewed as a point of curiosity rather than a medical diagnosis. You cannot use this information to predict your risk of disease or to guide your own medical treatment. If you have questions about inflammation, pain management, or the use of NSAIDs, you should always consult with a qualified clinician or pharmacist. They can provide personalized advice based on your full clinical picture rather than a single genetic marker.
How common is this variant?
The frequency of the rs689465 alleles varies significantly across different global populations, making it a highly variable marker depending on ancestral background.
Frequently asked questions
Does the rs689465 variant mean I have high inflammation?
No, this variant does not provide a direct measure of your current inflammation levels. Inflammation is a complex biological process influenced by many factors, and a single genetic variant is not a diagnostic tool for systemic health.
Should I change my diet based on my rs689465 genotype?
There is no established clinical guideline that recommends specific dietary changes based on this SNP. You should focus on a balanced, healthy diet and discuss any significant nutritional changes with a healthcare provider or registered dietitian.
Can this variant predict if NSAIDs will work for me?
While COX-2 is the target of NSAIDs, current research does not support using the rs689465 genotype to predict how well these medications will work for an individual. Always follow your doctor's instructions regarding medication use.
Is rs689465 a cause of cancer?
No, this variant is not a cause of cancer. Some studies have looked for statistical associations between this SNP and cancer risk, but these findings are inconsistent and do not imply a direct causal relationship.
Sources & further reading
Educational information only, last refreshed 10/27/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs689465?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29